Trial Profile
Propiverine hydrochloride extended release (ER): Tolerability in patients with LUTS and BPS/BPH A randomised, double-blind, placebo-controlled, multi-centre clinical trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jun 2023
Price :
$35
*
At a glance
- Drugs Propiverine (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- Sponsors Apogepha
- 21 Jun 2023 Status changed from recruiting to completed.
- 26 May 2011 New trial record